Early 2026 saw a 20% decline in venture capital funding for telemedicine startups, indicating a crucial shift in the MedTech market. This article delves into the factors driving this telemedicine funding drop, from market saturation to regulatory changes, and discusses the implications for industry consolidation and future growth.